EUVIMEDOpdag EUVIMED
CrossrefInfokort

Letter to the editor Intranasal sufentanil and its emerging clinical Applications: beyond its role in the emergency department

Shailendra Kapoor, MD

Journal of Opioid Management · 2012

DOI: 10.5055/10 ↗
AbstractBibliografiske oplysninger

Abstract

Dear Editor:I read with great interest the recent article by Stephen et al.(For instance, in a recent study, intranasal sufentanil was rated as a better alternative than prestudy breakthrough medication in 77 percent of patients with cancer. (1) Intranasal sufentanil is rapidly emerging as a treatment alternative in a number of other scenarios besides its role in achieving effective pain control in the emergency department. Intranasal administration is safe and provides rapid relief in patients with cancer who experience breakthrough cancer pain. The low prevalence of systemic side effects makes it an ideal option in patients with cancer.2)Read more...

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.

Se priser →